Deals Of The Week: Johnson & Johnson/Pharmacyclics, AstraZeneca/Guangdong BeiKang, AstraZeneca/Medical Research Council
Executive Summary
As more and more biopharmaceutical companies jump on the biosimilars train, the complexities of this emerging business area are becoming clear.